ETOPOSIDE
Breast Cancer Diagnosis
Graziella di GreziaSmall moleculePhase 2Active
BB
71/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Breast Cancer Diagnosis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FCH National Taiwan University Hospital | Phase 4 | BB |
GADOPENTETATE DIMEGLUMINE National Taiwan University Hospital | Phase 4 | B |
Evomela Graziella di Grezia | Phase 2 | B |
Same molecule, other indications
ETOPOSIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →